Periodic limb movement disorder (PLMD) is characterized an elevated number of periodic leg movements during sleep (PLMS) and nighttime or daytime symptoms not explained by the presence of other comorbidities. The accurate assessment of the prevalence and significance of PLMD is therefore clouded by the high number of comorbidities and medications that exacerbate or precipitate PLMS, such as antidopaminergics, antidepressants and antihistaminergics or kidney disease, heart disease and iron deficiency anemia. Due to the difficulty in identification of these patients, a wide variety of prevalence of PLMD in both adults and children has been reported. Furthermore, since the diagnosis of PLMD requires a PSG (not required by the diagnostic criteria of many other sleep disorders), its true prevalence remains unknown. Treatment options for PLMD include the same options than for patients with restless legs syndrome, oral or intravenous iron supplementation, dopamine agonists, gabapentin, opiods and, to a lesser extent, benzodiazepines. More research is needed in the area of PLMD, in both adults and children, to assess prevalence, natural progression of the disorder and consequences of untreated PLMD.

Periodic limb movement disorder / Ferri, R.; Delrosso, L. M.; Mogavero, M. P.; Bruni, O.. - (2023), pp. 620-627. [10.1016/B978-0-12-822963-7.00121-3].

Periodic limb movement disorder

Bruni O.
2023

Abstract

Periodic limb movement disorder (PLMD) is characterized an elevated number of periodic leg movements during sleep (PLMS) and nighttime or daytime symptoms not explained by the presence of other comorbidities. The accurate assessment of the prevalence and significance of PLMD is therefore clouded by the high number of comorbidities and medications that exacerbate or precipitate PLMS, such as antidopaminergics, antidepressants and antihistaminergics or kidney disease, heart disease and iron deficiency anemia. Due to the difficulty in identification of these patients, a wide variety of prevalence of PLMD in both adults and children has been reported. Furthermore, since the diagnosis of PLMD requires a PSG (not required by the diagnostic criteria of many other sleep disorders), its true prevalence remains unknown. Treatment options for PLMD include the same options than for patients with restless legs syndrome, oral or intravenous iron supplementation, dopamine agonists, gabapentin, opiods and, to a lesser extent, benzodiazepines. More research is needed in the area of PLMD, in both adults and children, to assess prevalence, natural progression of the disorder and consequences of untreated PLMD.
2023
Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
Electromyography; EMG; Endophenotype; Narcolepsy; Obstructive sleep apnea; Periodic leg movements during sleep; Periodic limb movement disorder; PLMD; PLMS; Polysomnography; Rapid eye movement sleep behavior disorder; RBD; Restless legs syndrome; RLS
02 Pubblicazione su volume::02a Capitolo o Articolo
Periodic limb movement disorder / Ferri, R.; Delrosso, L. M.; Mogavero, M. P.; Bruni, O.. - (2023), pp. 620-627. [10.1016/B978-0-12-822963-7.00121-3].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1692910
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact